The Effect of Bariatric Surgery on Diabetic Retinopathy: Good, Bad, or Both?

다국어 초록 (Multilingual Abstract)

Bariatric surgery, initially intended as a weight-loss procedure, is superior to standard lifestyle intervention and pharmacological therapy for type 2 diabetes in obese individuals. Intensive medical management of hyperglycemia is associated with improved microvascular outcomes. Whether or not the reduction in hyperglycemia observed after bariatric surgery translates to improved microvascular outcomes is yet to be determined. There is substantial heterogeneity in the data relating to the impact of bariatric surgery on diabetic retinopathy (DR), the most common microvascular complication of diabetes. This review aims to collate the recent data on retinal outcomes after bariatric surgery. This comprehensive evaluation revealed that the majority of DR cases remain stable after surgery. However, risk of progression of pre-existing DR and the development of new DR is not eliminated by surgery. Instances of regression of DR are also noted. Potential risk factors for deterioration include severity of DR at the time of surgery and the magnitude of glycated hemoglobin reduction. Concerns also exist over the detrimental effects of postprandial hypoglycemia after surgery. In vivo studies evaluating the chronology of DR development and the impact of bariatric surgery could provide clarity on the situation. For now, however, the effect of bariatric surgery on DR remains inconclusive.

참고문헌 (Reference)

1 Docherty NG, "Weight loss interventions and progression of diabetic kidney disease" 15 : 55-, 2015

2 Kumagai AK, "Upregulation of blood-brain barrier GLUT1 glucose transporter protein and mRNA in experimental chronic hypoglycemia" 44 : 1399-1404, 1995

3 Stratton IM, "UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6years from diagnosis" 44 : 156-163, 2001

4 Miras AD, "Type 2 diabetes mellitus and microvascular complications 1year after Roux-en-Y gastric bypass: a case-control study" 58 : 1443-1447, 2015

5 Brownlee M, "The pathobiology of diabetic complications: a unifying mechanism" 54 : 1615-1625, 2005

6 Amin AM, "The impact of bariatric surgery on retinopathy in patients with type 2 diabetes: a retrospective cohort study" 12 : 606-612, 2016

7 Cheung D, "The impact of bariatric surgery on diabetic retinopathy: a systematic review and meta-analysis" 25 : 1604-1609, 2015

8 Courcoulas AP, "Surgical vs medical treatments for type 2 diabetes mellitus: a randomized clinical trial" 149 : 707-715, 2014

9 Ikramuddin S, "Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial" 309 : 2240-2249, 2013

10 Banks J, "Roux-en-Y gastric bypass could slow progression of retinopathy in type 2 diabetes: a pilot study" 25 : 777-781, 2015

11 Dahl-Jorgensen K, "Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study" 290 : 811-815, 1985

12 Henricsson M, "Progression of retinopathy after improved metabolic control in type 2 diabetic patients. Relation to IGF-1 and hemostatic variables" 22 : 1944-1949, 1999

13 Murphy R, "Progression of diabetic retinopathy after bariatric surgery" 32 : 1212-1220, 2015

14 Villarroel M, "Neurodegeneration:an early event of diabetic retinopathy" 1 : 57-64, 2010

15 Brynskov T, "Monitoring of diabetic retinopathy in relation to bariatric surgery: a prospective observational study" 26 : 1279-1286, 2016

16 Fowler MJ, "Microvascular and macrovascular complications ofdiabetes" 26 : 77-82, 2008

17 Miras AD, "Metabolic surgery: shifting the focus from glycaemia and weight to end-organ health" 2 : 141-151, 2014

18 Forbes JM, "Mechanisms of diabetic complications" 93 : 137-188, 2013

19 Shichiri M, "Long-term results of the Kumamoto study on optimal diabetes control in type 2 diabetic patients" 23 (23): B21-B29, 2000

20 Abbatini F, "Long-term remission of type 2 diabetes in morbidly obese patients after sleeve gastrectomy" 9 : 498-502, 2013

21 Marso SP, "Liraglutide and cardiovascular outcomes in type 2 diabetes" 375 : 311-322, 2016

22 UK Prospective Diabetes Study (UKPDS) Group, "Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes" 352 : 837-853, 1998

23 Merimee TJ, "Insulin-like growth factors. Studies in diabetics with and without retinopathy" 309 : 527-530, 1983

24 Lammert A, "Improved arteriole-to-venule ratio of retinal vessels resulting from bariatric surgery" 20 : 2262-2267, 2012

25 Du XL, "Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation" 97 : 12222-12226, 2000

26 Ernest JT, "Hyperglycemia impairs retinal oxygen autoregulation in normal and diabetic dogs" 24 : 985-989, 1983

27 Duckworth W, "Glucose control and vascular complications in veterans with type 2 diabetes" 360 : 129-139, 2009

28 Yau JW, "Global prevalence and major risk factors of diabetic retinopathy" 35 : 556-564, 2012

29 Varadhan L, "GLP-1 agonist treatment: implications for diabetic retinopathy screening" 94 : e68-e71, 2011

30 Gandorfer A, "Epiretinal pathology of diffuse diabetic macular edema associated with vitreomacular traction" 139 : 638-652, 2005

31 Sena CM, "Endothelial dysfunction: a major mediator of diabetic vascular disease" 1832 : 2216-2231, 2013

32 ACCORD Study Group, "Effects of medical therapies on retinopathy progression in type 2 diabetes" 363 : 233-244, 2010

33 Zakaria AS, "Effects of gastric banding on glucose tolerance, cardiovascular and renal function, and diabetic complications: a 13-year study of the morbidly obese" 12 : 587-595, 2016

34 Beulens JW, "Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial" 52 : 2027-2036, 2009

35 Liang Z, "Effect of laparoscopic Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus with hypertension: a randomized controlled trial" 101 : 50-56, 2013

36 Singh RP, "Effect of bariatric surgery versus intensive medical management on diabetic ophthalmic outcomes" 38 : e32-e33, 2015

37 The Diabetes Control and Complications Trial Research Group, "Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial" 116 : 874-886, 1998

38 Thomas RL, "Does bariatric surgery adversely impact on diabetic retinopathy in persons with morbid obesity and type 2 diabetes? A pilot study" 28 : 191-195, 2014

39 Heng LZ, "Diabetic retinopathy: pathogenesis, clinical grading, management and future developments" 30 : 640-650, 2013

40 Davis MD, "Diabetic retinopathy. A clinical overview" 15 : 1844-1874, 1992

41 Ciulla TA, "Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies" 26 : 2653-2664, 2003

42 Antonetti DA, "Diabetic retinopathy" 366 : 1227-1239, 2012

43 Moreno A, "Diabetic retinopathy" 28 (28): 53-56, 2013

44 Grunwald JE, "Diabetic glycemic control and retinal blood flow" 39 : 602-607, 1990

45 Kim YJ, "Clinical course of diabetic retinopathy in Korean type 2 diabetes after bariatric surgery: a pilot study." 35 : 935-943, 2015

46 Phelps RL, "Changes in diabetic retinopathy during pregnancy. Correlations with regulation of hyperglycemia" 104 : 1806-1810, 1986

47 Mingrone G, "Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial" 386 : 964-973, 2015

48 Schauer PR, "Bariatric surgery versus intensive medical therapy for diabetes: 3-year outcomes" 370 : 2002-2013, 2014

49 Johnson BL, "Bariatric surgery is associated with a reduction in major macrovascular and microvascular complications in moderately to severely obese patients with type 2 diabetes mellitus" 216 : 545-556, 2013

50 Miras AD, "Bariatric surgery does not exacerbate and may be beneficial for the microvascular complications of type 2 diabetes" 35 : e81-, 2012

51 Jackson S, "Bariatric surgery and microvascular complications of type 2 diabetes mellitus" 16 : 453-, 2014

52 Varadhan L, "Bariatric surgery and diabetic retinopathy: a pilot analysis" 22 : 515-516, 2012

53 Cohen R, "Bariatric and metabolic surgery and microvascular complications of type 2 diabetes mellitus" 37 : 399-409, 2015

54 Moskalets E, "Association of blindness to intensification of glycemic control in insulin-dependent diabetes mellitus" 8 : 45-50, 1994

55 Sjostrom L, "Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications" 311 : 2297-2304, 2014

56 Fong DS, "American Diabetes Association. Retinopathy in diabetes" 27 (27): S84-S87, 2004

57 Sharma Y, "Advanced glycation end products and diabetic retinopathy" 5 : 63-69, 2013